Retail investors have been enamored with
$NUTX's cash and receivables, what they're missing:
- consolidated accounting with VIEs
- subsidiaries have minority owners
- 20-22% of cash and receivables don't belong to shareholders
- cash and receivables are at risk of mark downs and claw backs
- largest source of rev (~50%) BCBS, is furious and wants blood
- employers bear most of the costs from inflated arb awards
- employers directing their employees away from
$NUTX
-
$NUTX's profitability relies on ripping off payors.
Check why
$NUTX peers recently failed: Adeptus Health and American Physician Partners